Cargando…
Current Status and Future Perspectives on Machine Perfusion: A Treatment Platform to Restore and Regenerate Injured Lungs Using Cell and Cytokine Adsorption Therapy
Since its advent in the 1990′s, ex vivo lung perfusion (EVLP) has been studied and implemented as a tool to evaluate the quality of a donor organ prior to transplantation. It provides an invaluable window of opportunity for therapeutic intervention to render marginal lungs viable for transplantation...
Autores principales: | Niroomand, Anna, Hirdman, Gabriel, Olm, Franziska, Lindstedt, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750486/ https://www.ncbi.nlm.nih.gov/pubmed/35011653 http://dx.doi.org/10.3390/cells11010091 |
Ejemplares similares
-
Proteomic changes to immune and inflammatory processes underlie lung preservation using ex vivo cytokine adsorption
por: Niroomand, Anna, et al.
Publicado: (2023) -
Taking a Deep Breath: an Examination of Current Controversies in Surgical Procedures in Lung Transplantation
por: Hirdman, Gabriel, et al.
Publicado: (2022) -
Reduction of primary graft dysfunction using cytokine adsorption during organ preservation and after lung transplantation
por: Ghaidan, Haider, et al.
Publicado: (2022) -
Proteomic characteristics and diagnostic potential of exhaled breath particles in patients with COVID-19
por: Hirdman, Gabriel, et al.
Publicado: (2023) -
Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome
por: Edström, Dag, et al.
Publicado: (2023)